Results 41 to 50 of about 99,302 (260)

Adverse reactions of biological therapies in patients with psoriasis [PDF]

open access: yes, 2017
Psoriasis is a chronic, immune-mediated disorder characterized by well demarcated, erythematous plaques covered by thick, silvery-white scales, most often located on the knees, elbows, sacral area and scalp.
Georgescu, Simona R.   +5 more
core   +4 more sources

Prevalence of Hepatitis B and Hepatitis C Infections in a Tertiary Care Hospital, Telangana, India - Comparison of Pre-Pandemic and COVID-19 Pandemic times

open access: yesJournal of Pure and Applied Microbiology, 2022
WHO estimates show that 296 million people were living with chronic hepatitis B infection in 2019 with 1.5 million new infections occurring every year and approximately 290 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular ...
C. Roopa   +3 more
doaj   +1 more source

The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state [PDF]

open access: yes, 2016
Indexación: Web of ScienceWith about 350 million people chronically infected around the world hepatitis B is a major health problem. Template for progeny HBV synthesis is the viral genome, organized as a minichromosome (cccDNA) inside the hepatocyte ...
Alarcon, V   +9 more
core   +2 more sources

Hepatitis B Vaccination in Persons with Isolated Hepatitis B Core Antibodies [PDF]

open access: yesClinical Infectious Diseases, 1999
SIR-Silva et al. [1] suggested that in the population they have studied, isolated antibodies to hepatitis B core antigen (anti-HBc) are false-positive results. Their arguments are based on the facts that only five persons among the 133 investigated had hepatitis B virus (HBV) DNA detected in their serum and that most had a primary response to HBV ...
Brian J. McMahon, Alan J. Parkinson
openaire   +3 more sources

High prevalence of anti-hepatitis e virus antibodies among blood donors in central Italy, february to march 2014 [PDF]

open access: yes, 2016
Prevalence of anti-hepatitis E virus (HEV) antibodies is highly variable in developed countries, which seems partly due to differences in assay sensitivity.
Bruni, R.   +13 more
core   +1 more source

Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies

open access: yesMemorias do Instituto Oswaldo Cruz, 2006
In this report, we examine the adaptability of commercially available serological kits to detect antibodies markers for viral hepatitis in oral fluid samples. We also assessed the prevalence of hepatitis A, B, and C virus-specific antibodies, and related
Luciane A Amado   +4 more
doaj   +1 more source

Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice [PDF]

open access: yes, 2018
Hepatitis C virus (HCV) is a globally disseminated human pathogen for which no vaccine is currently available. HCV is highly diverse genetically and can be classified into 7 genotypes and multiple sub-types. Due to this antigenic variation, the induction
Bieńkowska-Szewczyk, Krystyna   +5 more
core   +1 more source

Paula Meehan’s Cell: The Imprisoned Dialogue of Female Discourses [PDF]

open access: yes, 2014
The paper discusses Paula Mehan’s play Cell with focus on the female discourses present in the context of this literary work and the multifold metaphorisation that both the title of the work and the contents invite.
August   +36 more
core   +2 more sources

Differential regulation of ZFAS1 splice variants by endoplasmic reticulum stress in hepatocyte cell lines

open access: yesFEBS Open Bio, EarlyView.
ZFAS1 is a lncRNA promoting cell proliferation and migration, exhibiting high expression in various cancers. It is conserved, widely expressed, and produces multiple splice variants with unclear roles. We identified several splice variants in hepatocyte models, and found that inhibiting or suppressing regulators of the unfolded protein response (PERK ...
Sébastien Soubeyrand   +2 more
wiley   +1 more source

Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Vaccination is the most effective and well-tolerated method of conferring long-term protection against hepatitis A and B viruses (HAV; HBV). Long-term studies are required to characterize the duration of protection and need for boosters.
Pierre Van Damme   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy